Celanese SVP & CFO reports 5,000-share insider transaction

Celanese Corp insider Chuck Kyrish, the company’s SVP & CFO, reported an equity transaction involving 5,000 shares of Celanese common stock on December 9, 2025, at a weighted average price of about $41.03 per share.

Rhea-AI Filing Summary

Celanese Corp insider Chuck Kyrish, the company’s SVP & CFO, reported an equity transaction involving 5,000 shares of Celanese common stock on December 9, 2025, at a weighted average price of about $41.03 per share. After this activity, he beneficially owned 10,914.476 shares directly. The filing notes that the shares were executed in multiple trades within a price range from $40.885 to $41.112, and that detailed trade-by-trade information is available from the reporting person upon request.

Insider Trade Summary

Net Buyer: 5,000 shares

Net Buy 1 txn

Insider Kyrish Chuck

Role SVP & CFO

Bought 5,000 shs ($205K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	5,000	$41.03	$205K

Holdings After Transaction: Common Stock — 10,914.476 shares (Direct)

Footnotes (1)

1. F1. The reported price in this line is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $40.885 to $41.112. The reporting person will provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Celanese (CE) report in this Form 4?

The Form 4 reports that SVP & CFO Chuck Kyrish had an equity transaction involving 5,000 shares of Celanese common stock on December 9, 2025 at a weighted average price of $41.03 per share.

What is the role of the reporting person in Celanese (CE)?

The reporting person, Chuck Kyrish, is identified as an officer of Celanese Corp, serving as SVP & CFO.

How many Celanese (CE) shares does the insider own after the reported transaction?

Following the reported transaction, the insider beneficially owns 10,914.476 shares of Celanese common stock, held directly.

At what prices were the Celanese (CE) shares traded in this insider transaction?

The filing states that the 5,000 shares were executed in multiple trades at prices ranging from $40.885 to $41.112, with a weighted average price of $41.03 per share.

Was the Celanese (CE) insider transaction under a Rule 10b5-1 trading plan?

The form includes a checkbox for transactions under a Rule 10b5-1(c) trading plan, but the provided excerpt does not show this box as checked for the reported transaction.

Is detailed trade information for this Celanese (CE) insider transaction available?

Yes. The filing states that the reporting person will provide to the Company, any security holder, or the SEC staff, upon request, full information on the number of shares traded at each price within the reported range.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/11/2025 - 04:28 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kyrish Chuck

(Last) (First) (Middle)

C/O 222 W LAS COLINAS BLVD, SUITE 900N

(Street)

IRVING TX 75039

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Celanese Corp [ CE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & CFO

3. Date of Earliest Transaction (Month/Day/Year)
12/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/09/2025		P		5,000	A	$41.03(1)	10,914.476	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported price in this line is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $40.885 to $41.112. The reporting person will provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price.

Remarks:

	/s/ Blake Feikema, Attorney-in-Fact for Chuck Kyrish	12/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.